Serina Therapeutics, Inc.
SER
$5.67
-$0.1173-2.03%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -11.14M | -7.35M | -7.01M | -5.83M | 5.27M |
| Total Depreciation and Amortization | 194.00K | 144.00K | 142.00K | 102.00K | 90.00K |
| Total Amortization of Deferred Charges | 345.00K | 337.00K | 329.00K | 22.00K | -- |
| Total Other Non-Cash Items | -3.22M | -2.16M | 437.00K | 1.86M | -7.92M |
| Change in Net Operating Assets | -3.32M | -3.39M | -4.39M | 501.00K | 81.00K |
| Cash from Operations | -17.14M | -12.43M | -10.49M | -3.34M | -2.48M |
| Capital Expenditure | -22.00K | -87.00K | -203.00K | -518.00K | -504.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.00K | -87.00K | -203.00K | -518.00K | -504.00K |
| Total Debt Issued | 3.04M | 2.93M | 2.93M | 2.40M | 10.10M |
| Total Debt Repaid | -168.00K | -180.00K | -184.00K | -50.00K | -48.00K |
| Issuance of Common Stock | 10.00M | 5.08M | 5.01M | 19.00K | 15.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 337.00K | 337.00K | 337.00K | 337.00K | -- |
| Cash from Financing | 13.21M | 8.17M | 8.08M | 2.71M | 10.07M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.95M | -4.35M | -2.61M | -1.16M | 7.09M |